标题 |
Cost-effectiveness analysis of insulin aspart 30 versus insulin glargine in patients with type 2 diabetes in China
门冬胰岛素30与甘精胰岛素治疗2型糖尿病的成本——效果分析
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
Chinese Pharmaceutical Journal ; (24): 242-247, 2016. Artigo em Chinês | WPRIM (Pacífico Ocidental) | ID: wpr-859229 Biblioteca responsável: WPRO |
求助人 | |
下载 |